Sentinel lymph node (SLN) biopsy is a rapidly emerging treatment option for the patient with
early stage invasive breast cancer and a clinically negative axilla. In the era of …

Background. Breast cancer treatment has rapidly changed in the last few years. Particularly,
treatment of patients with axillary nodal involvement has evolved after publication of several …

The tumor status of the axillary lymph nodes is the single most important predictor of survival
for patients with primary breast cancer. Because of its essential role in staging, regional …

Breast cancer remains a major cause of cancer death for women in the United States.
Accurate cancer staging, especially of the axillary lymph nodes, is essential for predicting …

Sentinel lymph node biopsy (SLNB) has become the standard of care for early breast
cancer. Its use in breast cancer has been evaluated in several randomized controlled trials …

Purpose Sentinel lymph node biopsy (SLNB) is an accurate and effective means of axillary
nodal staging in early breast cancer. However its indication after neoadjuvant chemotherapy …

Purpose This study aimed to evaluate the effects of sentinel lymph node biopsy (SLNB) on
recurrence and survival after neoadjuvant chemotherapy (NAC) in breast cancer patients …

Background Sentinel node biopsy (SNB) has been proposed as an alternative to axillary
lymph-node dissection (ALND) in breast cancer. Before implementing SNB in our practice …

Sentinel lymph node biopsy (SLNB) emerged in the 1990s as a new technique in the
surgical management of the axilla for patients with early breast cancer, resulting in lower …

Sentinel lymph node biopsy has rapidly become the standard of care in the primary
treatment of breast cancer. Most of the initially identified potential contraindications towards …